PI
BIIB icon

PEAK6 Investments’s Biogen BIIB Stock Holding History

PEAK6 Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,416
Closed -$3.13M – 3581
2024
Q1 		$3.11M Buy
14,416
+5,014
+53% +$1.17M 0.01% 1129
2023
Q4 		$2.43M Sell
9,402
-6,106
-39% -$1.5M 0.01% 1359
2023
Q3 		$3.99M Buy
15,508
+15,071
+3,449% +$4.03M 0.02% 865
2023
Q2 		$124K Sell
437
-4,809
-92% -$1.43M ﹤0.01% 3140
2023
Q1 		$1.46M Buy
5,246
+5,243
+174,767% +$1.45M 0.01% 1555
2022
Q4 		$734 Buy
3
+1
+50% +$282 ﹤0.01% 4262
2022
Q3 		$1K Sell
2
-435
-100% -$92.4K ﹤0.01% 4760
2022
Q2 		$124K Sell
437
-78,177
-99% -$16M ﹤0.01% 3141
2022
Q1 		$16.6M Buy
78,614
+20,035
+34% +$4.36M 0.04% 478
2021
Q4 		$14.1M Sell
58,579
-48,840
-45% -$12.6M 0.03% 562
2021
Q3 		$30.4M Sell
107,419
-37,407
-26% -$12.3M 0.07% 246
2021
Q2 		$50.1M Buy
144,826
+70,390
+95% +$21.3M 0.12% 145
2021
Q1 		$20.8M Sell
74,436
-127,486
-63% -$34.4M 0.05% 337
2020
Q4 		$49.4M Buy
201,922
+130,144
+181% +$33.6M 0.1% 168
2020
Q3 		$20.4M Sell
71,778
-16,612
-19% -$4.63M 0.05% 327
2020
Q2 		$23.6M Sell
88,390
-18,289
-17% -$5.5M 0.08% 222
2020
Q1 		$33.8M Buy
106,679
+36,684
+52% +$11.1M 0.2% 91
2019
Q4 		$20.8M Buy
69,995
+13,528
+24% +$3.75M 0.11% 177
2019
Q3 		$13.1M Buy
56,467
+2,597
+5% +$605K 0.08% 260
2019
Q2 		$12.6M Sell
53,870
-17,569
-25% -$4.06M 0.08% 286
2019
Q1 		$16.9M Buy
71,439
+57,488
+412% +$18.1M 0.1% 210
2018
Q4 		$4.2M Buy
+13,951
New +$4.45M 0.03% 743

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PEAK6 Investments's BIIB Position: Q2 2024 in Review

PEAK6 Investments sold out of Biogen (BIIB) in Q2 2024, closing a stake of 14,416 shares — an estimated $3.13M sold.

PEAK6 Investments first reported a position in BIIB in Q4 2018 and held it in 22 quarters. The position peaked at $50.1M in Q2 2021. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • PEAK6 Investments reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 14,416 Biogen shares in Q2 2024, an estimated $3.13M.
  • PEAK6 Investments first reported a position in Biogen in Q4 2018 and held it in 22 quarters.
  • PEAK6 Investments's Biogen position peaked at $50.1M in Q2 2021.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.